Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jiage Ding"'
Autor:
Zheng Lu, Gang Wang, Junnian Zheng, Lin Fang, Fei Zhu, Wenjing Tang, Guangya Zhao, Yingxiang Shao, Bowen Lu, Jiage Ding, Yanyan Zheng, Huizhong Li, Renjin Chen, Dafei Chai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
Background Targeting kinases presents a potential strategy for treating solid tumors; however, the therapeutic potential of vaccines targeting kinases remains uncertain.Methods Adenovirus (Ad) vaccines encoding Aurora kinase A (AURKA) or cyclin-depen
Externí odkaz:
https://doaj.org/article/5fe9b37062a84aa0a9b5e87779733f13
Autor:
Nan Jiang, Yanyan Zheng, Jiage Ding, Jiawei Wang, Fei Zhu, Meng Wang, Navid Sobhani, Praveen Neeli, Gang Wang, Hailong Li, Junnian Zheng, Dafei Chai
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-13 (2023)
Abstract Immune-based checkpoint therapy has made significant progress in cancer treatment, but its therapeutic effect is limited. A replication-defective adenovirus (Ad) vaccine encoding tumor antigen carbonic anhydrase IX (CAIX) combined with Ad-en
Externí odkaz:
https://doaj.org/article/2d71624d4c684ce5b5ddb3fcaa660d70
Autor:
Xiaoqing Shi, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, Junnian Zheng, Dafei Chai
Publikováno v:
iScience, Vol 26, Iss 3, Pp 106143- (2023)
Summary: Hepatocellular carcinoma (HCC) is a fatal malignant tumor, but effective clinical interventions are limited. PLGA/PEI-mediated DNA vaccine encoding the dual targets of high-mobility group box 1 (HMGB1) or GPC3 was developed for HCC treatment
Externí odkaz:
https://doaj.org/article/deffea18b5b34f5b9994c81b80a42ee0
Autor:
Dafei Chai, Dong Qiu, Xiaoqing Shi, Jiage Ding, Nan Jiang, Zichun Zhang, Jiawei Wang, Jie Yang, Pengli Xiao, Gang Wang, Junnian Zheng
Publikováno v:
Molecular Therapy: Oncolytics, Vol 24, Iss , Pp 1-13 (2022)
Tumor DNA vaccine as an effective therapeutic approach can induce systemic immunity against malignant tumors, but its therapeutic effect is still not satisfactory in advanced renal cancer. Herein, a novel DNA vaccine containing dual antigens of fibri
Externí odkaz:
https://doaj.org/article/39335386d18447288a071bbdb446c657
Autor:
Qing Zhang, Haixu Zhang, Jiage Ding, Hongyan Liu, Huizhong Li, Hailong Li, Mengmeng Lu, Yangna Miao, Liantao Li, Junnian Zheng
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Externí odkaz:
https://doaj.org/article/028845ec7d2c44adaeff7748768d9c74
Autor:
Qing Zhang, Haixu Zhang, Jiage Ding, Hongyan Liu, Huizhong Li, Hailong Li, Mengmeng Lu, Yangna Miao, Liantao Li, Junnian Zheng
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Adoptive chimeric antigen receptor-modified T or NK cells (CAR-T or CAR-NK) offer new options for cancer treatment. CAR-T therapy has achieved encouraging breakthroughs in the treatment of hematological malignancies. However, their therapeutic effica
Externí odkaz:
https://doaj.org/article/7ed0fc0fa5974024a0cc7eff09e02d29
Autor:
Qing Zhang, Jie Yang, Nan Jiang, Lin Fang, Shang Yuchen Shi, Dong Qiu, Gang Wang, Zichun Zhang, Junnian Zheng, Dafei Chai, Jiage Ding, Huizhong Li, Hui Tian
Publikováno v:
Cancer Science
Renal carcinoma shows a high risk of invasion and metastasis without effective treatment. Herein, we developed a chitosan (CS) nanoparticle‐mediated DNA vaccine containing an activated factor L‐Myc and a tumor‐specific antigen CAIX for renal ca
Autor:
Yanyan, Zheng, Zheng, Lu, Jiage, Ding, Nan, Jiang, Jiawei, Wang, Jie, Yang, Jingyuan, Song, Hongliang, Chen, Lin, Fang, Huizhong, Li, Hui, Tian, Gang, Wang, Junnian, Zheng, Dafei, Chai
Publikováno v:
Cancers. 14(18)
Hepatocellular carcinoma (HCC) is one of the cancers with the highest morbidity and mortality in the world. However, clinical progress in the treatment of HCC has not shown a satisfactory therapeutic effect. Here, we have developed a novel strategy t
Autor:
Dafei Chai, Shang Yuchen Shi, Navid Sobhani, Jiage Ding, Zichun Zhang, Nan Jiang, Gang Wang, Minle Li, Hailong Li, Junnian Zheng, Jin Bai
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2861
Interferon-induced protein 35 (IFI35), is currently acknowledged to govern the virus-related immune inflammatory responses. However, the biological significance and function of IFI35 in renal cell cancer (RCC) is still not well understood. Here, IFI3
Autor:
Xiaoqing Shi, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, Junnian Zheng, Dafei Chai
Publikováno v:
SSRN Electronic Journal.